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Abstract 
Purpose: To validate a new and simple method for cleaning a manufacturing line for creams and 
ointments.  
Methods: The worst case product of the line chosen was a cream containing three practically insoluble 
ingredients: betamethasone, tolnaftate and cliquinol. The cleaning method utilized hot water and a 
commercial detergent, followed by rinsing. Validation methods included the visual inspection of the 
machine surface, swab sampling, microbial bioburden determination and testing the final rinse for 
conductivity, pH and total organic carbon (TOC) limits.  Acceptance limit calculations depended on the 
figure tip unit (FTU).  
Results: No visual residue or chemical residue was detected above 674.37 ppm, which is the maximum 
allowable carry-over level of the drug. Similarly, microbial bioburden was < 25 CFU/swab - the 
acceptable limit.   
Conclusion: The method adopted to get rid of insoluble drug residue and microorganism from the 
cream and ointment production facility was successful. The method is simple and reproducible as 
indicated by the results of the three cleaning cycles.     
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Pharmaceutical products can be contaminated 
by a variety of substances, such as microbes and 
previous products (both active pharmaceutical 
ingredients and excipient residues). Other 
contaminants include residues of cleaning 
agents, airborne materials, and ancillary 
materials such as disinfectants.  Contamination 
can also occur due to decomposition of product 
residue and breakdown products of the 
detergents, acids and alkalis that may be used 
as part of the cleaning process [1]. 
 
Cleaning validation is a documented proof that 
one can consistently and effectively clean a 
system or equipment items [2].  Cleaning 
involves removing an unwanted substance (the 
contaminant) from a surface (the equipment to 
be cleaned) [3-5].  The cleaning mechanisms 
depend on properties of the contaminant to be 
removed. Cleaning of manufacturing machines 
can be carried out using methods as “Clean in 
place (CIP)” [6], “Clean out of place (COP)” [7] 
and “Manual cleaning” [7,8] . 
 
There is a time limitation, such as microbiological 
contamination or carryover of degradation 
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products which might develop with time, or 
simply the ease of cleaning residues of product 
before they dry out on the equipment [9].  There 
are four time limitations: Clean holding time 
[10,11], dirty holding time [9,10], time between 
the cleaning and drying process [9] and a time 
limitation related to the frequency of cleaning 
between batches [9]. 
 
Cleaning can be achieved through the use of 
water, solvents, commodity chemicals and 
formulated cleaning agents [3,9,12] .   
 
Elements of cleaning validation[1,8] ,  include 
worst case determination [1,13,14], 
establishment of acceptance criteria [15,16], 
sampling procedure [1,17,18], analytical method 
and its validation [13,19], validation protocol 
[1,6,17,20], and cleaning validation report [1,21]. 
 
Topical semi-solid formulations such as creams 
and ointments contain greasy ingredients such 
as waxes and oils. These ingredients may inhibit 
wetting by cleaning agents, thereby limiting the 
ability to clean the residual product away [22].  
The active pharmaceutical ingredients and 
excipients commonly used in topical formulations 
may produce significant adverse effects. 
Therefore, one must determine the carryover of 
residues from one product to another in a 
scientifically justified manner to limit the possible 
interactions between products and their 
ingredients [22]. 
 
Hence, the objective of the work was to validate 
the suggested cleaning procedure and ensure 
that residues of previous product are removed in 
accordance with the maximum allowable 
carryover limit calculated 
 
The minimum and maximum daily dose of topical 
formulations can be calculated based on the 
criteria of finger-tip unit (FTU).  This criterion 
describes the dosage of topical formulations.  
[23]. Accordingly, the maximum allowable 
carryover limit can be calculated from Eq 1 [24]. 
 
MACO = (TDD×MBS×SF)/LDD ………………. (1) 
 
Where, MACO is the maximum allowable 
carryover, TDD the minimum daily dose of the 
previous product, and MBS the minimum batch 
size of next product.  It is obtained from the 
product matrix; LDD is the largest daily dose of 
the next product; SF is the safety factor = 1/100 
for topical products [25]. 
 
Calculation of limit in the analyzed sample is as 
in Eq 2. 
 
MACOs = (MACO cal×SA×RF)/( TSA×EV)….(2) 
 
where, MACOs is the maximum allowable 
carryover in the sample, MACO cal is the 
calculated MACO, SA is the area swabbed = 25 
cm2; TSA is the total equipment surface area that 
comes in contact with the product; RF is the 
recovery factor; EV is the extraction solvent 
volume ( the volume used to extract residue from 




The cream and ointment facility  
 
The cleaning process and its validation were 
performed for a cream and ointment production 
line involved in the production of twenty one 
products. The validation process involved three 
consecutive batches of the worst-case product. 
 
The facility consisted of three main parts: the 
cream and ointment preparation tank (Olsa 
S.P.V, Milano, Italy) (Figure 1), where mixing and 
homogenization of the bulk took place. The 
transfer bin (Figure 2), received the bulk 
prepared cream and ointment from the 
preparation tank which would be transferred to 
the third part: cream and ointment filling machine 
(Tonazzi, Marchesini group, Bologna, Italy) 
(Figure 3). A vacuum and pressure pump (Figure 
4) transferred the bulk cream or ointment to the 




Figure 1: Cream and ointment preparation tank 
(OLSA 500) 
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Figure 5: Feeding hopper and filling nozzle 
 
This facility was used to prepare 21 products. 
The worst case product chosen for the validation 
of the cleaning procedure was chosen based on 
the solubility of the active ingredients and the 
machine usage time in product manufacture. 
From the matrix of products of the facility, it was 
found that product F contained three practically 
insoluble ingredients: betamethasone valerate, 
tolnaftate and cliquinol [26].  Also, product F 
cream had the largest percentage of the machine 
usage time due to its frequent production and a 
large batch size. 
 
Three consecutive batches of the worst case 
product were taken into account to validate the 
corresponding cleaning procedures for the 
machines. Cleaning and sampling were 




The cleaning procedure involved a commercial 
detergent (Kamena L.A.11) with the following 
specifications: 
 
Anionic active material 5 - 15 %, non-ionic 
surfactant 5 %, preservative 5 %, viscosity: 200 - 
600 cps at 25 oC and color was clear light yellow 
at 25 oC. 
 
Procedure for cleaning the preparation tank 
 
A quantity of 500 liters of hot purified water (70 – 
90 oC) was added to the preparation tank with 
stirring by operating the inner mixer for 15 min to 
get rid of any remaining product residue and then 
the water was discarded. The tank was washed 
with 100 liters of purified water mixed with the 
detergent (60 ml detergent to each 1 liter of 
purified water), then the inner and outer tank 
mixers were operated as well as operating the 
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homogenizer for 30 min. Then, the solution was 
discarded and the preparation tank was filled 
with 250 liters of hot purified water (70 – 90 oC), 
the inner and outer mixers and the homogenizer 
were operated for 15 min for rinsing the tank 
followed by solution discarding. The above was 
repeated using 250 liters of purified water for 
rinsing the tank. The tank was then dried with 
compressed air and sprayed with isopropyl 
alcohol 70 %. 
 
Procedure for cleaning transfer bin 
 
The inner surface of the transfer bin, the cover 
and the stainless steel tube were washed first 
with hot purified water (70 – 90 oC) to get rid of 
any remaining product residues. Then, they were 
washed with the detergent and hot purified water 
(70 – 90 oC), rinsed with hot purified water (70 – 
90 oC) and finally with purified water two times 
before they were dried with compressed air and 
sprayed with isopropyl alcohol 70 %. 
 
Procedure for cleaning of cream and 
ointment filling machine 
 
Tubes were removed from the machine. Any 
product residue appearing on the machine 
surface was removed. The machine parts were 
dismantled (hopper, transfer hoses, filling nozzle 
and the machine set) and transferred to the 
washing room. The machine body was wiped 
with clean cloth soaked in hot purified water (50 
– 60 oC) followed by another one with purified 
water and dried with compressed air then 
sprayed with isopropyl alcohol 70 %. 
 
In the washing room, the machine parts were 
washed with hot purified water (70 –90 oC) first, 
then, washed with detergent and hot purified 
water. Then, followed the rinsing with hot purified 
water (70 – 90 oC), and with purified water two 
times. The machine parts were dried with 
compressed air and sprayed with isopropyl 
alcohol 70 %.  The machine parts were then 
reassembled to the machine body. 
 
Validation of the cleaning procedure 
 
After the cleaning process ended, the following 
steps were applied to validate the process. 
 
Visual inspection: to ensure absence of product 
or detergent residue on machine surface.  Visual 
examination was conducted under a light 
intensity of 750 lux and an angle of incidence of 
90 o. The distance between the eye and the 
surface examined was 30 cm, and duration of 
observation was 20 seconds. 
 
Swab samples  
 
These were taken from machine parts which 
were critical hard to clean areas (Appendix 2). 
The swab tubes were prepared by placing 5 ml of 
acidified ethanol (0.1 N hydrochloric acid in 
ethanol 96 %) in each swab tube. The area to be 
sampled was marked by using stencil 25 cm2 (5 
cm x 5 cm). The swab head moistened with 
acidified ethanol was held and the area to be 
sampled was wiped in a zigzag shape 
horizontally and vertically. The swab tube was 
labeled corresponding to the sample location. 
The tube carrying the swab head was placed in a 
sonicator for 30 minutes (test solution).  Swab 
samples were analyzed for maximum allowable 
carryover (MACO) of betamethasone valerate, 
tolnaftate and cliquinol [27]. 
 
Stock standard solutions were prepared using 
0.1 N hydrochloric acid in 96 % ethanol, to obtain 
a solution of 12 mg % of betamethasone valerate 
(solution A), a solution of 100 mg % cliquinol 
(solution B) and a solution of 100 mg % of 
tolnaftate (solution C). A standard solution 
containing the three ingredients was prepared by 
mixing 5 ml of solution A with 10 ml of each of 
solutions of B and C. 
 
The standard and the test solutions were filtered 
on 0.45 µm membrane filter, and injected on 
HPLC in accordance to the general method of 
analysis. The analysis conditions involved a C18 
column, 4.6 x 250 mm x 5 µm. The mobile phase 
was a mixture of acetonitrile and water (65:35), 
adjusted to a pH of 3.0 with phosphoric acid. The 
flow rate was set at 1.5 ml / minute and the 
injection volume was 10 µl. 
 
The content of each ingredient in the samples 
was calculated as in Eq 3. 
 
Drug Content = (Pt)/( Pstd)×Cstd×1000………(3) 
 
Where Pt is the peak area of drug in the test 
solution, and Pstd is the peak area of drug in the 
standard solution, and Cstd is the concentration of 




Microbiological monitoring of the machine 
surface was done after machine drying. 
Microbiological samples were taken in a manner 
similar to swab sampling, yet sterile cotton swabs 
were used, and the sampled areas were 25 cm2 
[4,28,29]. The swab head was taken from the 
swab tube and used to wipe the surface of a 
prepared agar plate. The agar plates were then 
incubated at (32 - 38 oC) for five days. At the end 
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of the incubation period, the growth of 
microorganisms was observed and the results 
were recorded. Criteria of clean room standard 
for surface swab test were used: there should be 
no more than 25 CFU/swab 25 cm2 [1]. 
 
Rinse sample: Rinse sample of 500 ml was 
collected before spraying alcohol on the machine 
parts to prevent interference.  Final rinse 
samples were tested for their TOC (total organic 
carbon), pH and conductivity limits, using a TOC 
analyzer, pH meter and conductivity meter, 
respectively. TOC, pH and conductivity should 
conform to the specifications for water for 
injection. Thus TOC should not exceed 500 ppm. 
pH limit should be from 5 - 7. Conductivity should 




The calculated maximum allowable carryover 
level of the drug in the sample was found to be 
674.37 ppm. Results obtained after chemical 
testing of betamethasone valerate, cliquinol and 
tolnaftate residue by swab sampling of hard to 
clean (critical area) of the surface of cream and 
ointment preparation tank, transfer bin and filling 
machine - after three cleaning cycles, were 
below the acceptance criteria. 
 
Visual inspection of machine surfaces showed no 
residue. The results of microbiological testing 
showed that the different machine parts 





TOC analysis for cream and ointment 
preparation tank was not conforming to 
specification as it was found to be above 500 
ppb.  A blank sample was taken from the purified 
water source that was used for washing the 
cream and ointment preparation tank to measure 
its TOC content.  The results were found within 
the limit.  Thus the cause of the high TOC results 
was probably due to the presence of detergent 
residue. Consequently, the rinsing time of the 
tank was increased to be 30 min using hot 
purified water (70 - 90 oC) instead of 15 min. 
Sample repetition and analysis of the final rinse 
showed that the results were conforming to 
specifications. Thus, the cleaning procedure was 
changed to a rinsing time of 30 min and applying 
this during routine work. 
 
The results of second and third washes all 
conformed to acceptance criteria.  No residue 
was visible on the machine surfaces.  Chemical 
analysis of the swab samples showed that the 
level of the active pharmaceutical ingredient was 
below the acceptance limits. Also the 
microbiological testing showed that all the 
surfaces conformed to the acceptance levels. 
The conductivity, pH measurements as well as 
the TOC measurements all conformed to the 
acceptance criteria after extending the rinsing 




The MACO was calculated using the FTU [24]. 
The FTU was assumed to be 20.25 g which was 
enough to cover the whole body, multiplied by 
four as the cream was applied four times daily 
[25].  The product of such multiplication produced 
the LDD (largest daily dose) of the next product. 
By knowing the MACO (674.37 ppm), it was 
possible to determine the maximum limit of 
product in the analyzed sample. Swab samples 
removed from critical hard to clean areas were 
taken as measure to the extent of success of the 
cleaning method to achieve its goal [1,17,18]. 
 
Indirect sampling of cleaned surfaces was 
achieved through the rinse samples. Such 
samples showed to be of great value so as to 
detect detergent residue [18], especially in areas 
which were almost impossible to be accessible to 
swabs.  Indirect sampling proved that fifteen 
minutes of rinsing were not enough to remove 
detergent residue. Thus, an extension of the 
rinsing time to thirty minutes was done which 
ensured effective detergent residue removal. 
 
It is clear that the choice of a sensitive method of 
analysis is important to detect any residual 
product, and hence the level of cleanliness 
achieved [13].  Hence, the use of the HPLC 
method of analysis of the three components of 




It is possible to clean a cream and ointment 
production and filling facility by a simple method 
using purified water and a commercial detergent. 
The method proved to be reproducible where 
results obtained after three cleaning cycles 
showed that chemical and microbiological 
residues were below the maximum allowable 
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